All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F23%3A73614534" target="_blank" >RIV/61989592:15110/23:73614534 - isvavai.cz</a>

  • Result on the web

    <a href="https://ascopubs.org/doi/pdf/10.1200/JCO.22.00269?role=tab" target="_blank" >https://ascopubs.org/doi/pdf/10.1200/JCO.22.00269?role=tab</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1200/JCO.22.00269" target="_blank" >10.1200/JCO.22.00269</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia

  • Original language description

    PURPOSE Germline missense variants of unknown significance in cancer-related genes are increasingly beingidentified with the expanding use of next-generation sequencing. The ataxia telangiectasia–mutated (ATM) geneon chromosome 11 has more than 1,000 germline missense variants of unknown significance and is a tumorsuppressor. We aimed to determine if rare germline ATM variants are more frequent in chronic lymphocyticleukemia (CLL) compared with other hematologic malignancies and if they influence the clinical characteristicsof CLL.METHODS We identified 3,128 patients (including 825 patients with CLL) in our hematologic malignancy clinicwho had received clinical-grade sequencing of the entire coding region of ATM.We ascertained the comparativefrequencies of germline ATM variants in categories of hematologic neoplasms, and, in patients with CLL, wedetermined whether these variants affected CLL-associated characteristics such as somatic 11q deletion.RESULTS Rare germline ATM variants are present in 24% of patients with CLL, significantly greater than that inpatients with other lymphoid malignancies (16% prevalence), myeloid disease (15%), or no hematologicneoplasm (14%). Patients with CLL with germline ATM variants are younger at diagnosis and twice as likely tohave 11q deletion. The ATM variant p.L2307F is present in 3% of patients with CLL, is associated with a threefoldincrease in rates of somatic 11q deletion, and is a hypomorph in cell-based assays.CONCLUSION Germline ATM variants cluster within CLL and affect the phenotype of CLL that develops, implyingthat some of these variants (such as ATM p.L2307F) have functional significance and should not be ignored.Further studies are needed to determine whether these variants affect the response to therapy or account forsome of the inherited risk of CLL.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    JOURNAL OF CLINICAL ONCOLOGY

  • ISSN

    0732-183X

  • e-ISSN

    1527-7755

  • Volume of the periodical

    41

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    13

  • Pages from-to

    1116-1128

  • UT code for WoS article

    000946950600022

  • EID of the result in the Scopus database

    2-s2.0-85147720497